Saeed, Mohsan
Andreo, Ursula
Chung, Hyo-Young
Espiritu, Christine
Branch, Andrea D.
Silva, Jose M.
Rice, Charles M.
Article History
Received: 27 November 2014
Accepted: 14 July 2015
First Online: 12 August 2015
Competing interests
: C.M.R. has equity in Apath, LLC, which holds commercial licenses for the Huh-7.5 cell line and certain HCV cell culture systems.